Single‐Center Randomized Evaluation of Paclitaxel‐Eluting Versus Conventional Stent in Acute Myocardial Infarction (SELECTION)

Abstract

PES was superior to its corresponding BMS in reducing NIH in the STEMI setting without any increase in early and long-term clinical adverse events.